A Question of Beneficence: Comorbidity Assessment to Ascertain Potential Benefit of CD19 Chimeric Antigen Receptor T Cells for Patients with Diffuse Large B Cell Lymphoma TRANSPLANTATION AND CELLULAR THERAPY Smith, M. 2021; 27 (1): 2-3

View details for DOI 10.1016/j.jtct.2020.11.002

View details for Web of Science ID 000619132900027